Alectinib Hydrochloride (CAS 1256589-74-8)
« Back to Anti-Cancer API
Alectinib Hydrochloride
CAS No. 1256589-74-8
盐酸阿来替尼
Chemical structure
| CAS No. | 1256589-74-8 |
|---|---|
| Synonyms | 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile hydrochloride (1:1) |
| Category | Anti-Cancer API / Anti-Cancer |
| Assay / Purity | 99% |
| Molecular Formula | C30H35ClN4O2 |
| Molecular Weight | 519.1 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Alectinib hydrochloride is a highly selective, CNS-penetrant ALK inhibitor supplied as the hydrochloride salt. It is used in oral capsules for ALK-positive non-small cell lung cancer, including patients with CNS metastases. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Cabozantinib Malate (CAS 1140909-48-3)
- Crizotinib (CAS 877399-52-5)
- Dacomitinib (CAS 1110813-31-4)
- Galunisertib (CAS 700874-72-2)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 1256589-74-8 · PubChem CID 53239799